InvestorsHub Logo

rlee47

11/05/18 2:23 PM

#6708 RE: treit2002 #6707

Will Medicare (and by extension most insurers) approve it for their formulary? If so, will they cap the reimbursement price at some unprofitable level? Has NBEV explored this issue?

oiledgearz

11/05/18 4:43 PM

#6711 RE: treit2002 #6707

PS- I am also sensing that slowly but surely, NBEV is gaining traction on its core brands. I see the range of Marley/Xing/Bucha offerings at my local Weis Market, and they are moving.

It's anecdotal at this point... but I've tried the products and they are quite good, others have said so as well. With all the hype surrounding CBD and NBEV, more people have heard of it and are trying their products.

I'm betting we see a strong, continual upswing, quarter over quarter over quarter, in sales...